Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fondazione Toscana Gabriele Monasterio | OTHER |
| Azienda USL Toscana Sud Est | OTHER_GOV |
| Azienda USL Toscana Nord Ovest | OTHER |
| Azienda Ospedaliero-Universitaria Careggi |
Not provided
Not provided
Not provided
Not provided
Not provided
Aim of the project is the development of an integrated platform, based on machine learning and omic techniques, able to support physicians in as much as possible accurate diagnosis of Type 1 Brugada Syndrome (BrS).
The aim of BrAID project is to integrate classic clinical guidelines for Brugada Syndrome 1 diagnosis evaluation with innovative Information and Communication Technologies and omic approaches, generating new diagnostic strategies in cardiovascular precision medicine of this disease.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients affected by Brugada Syndrome 1 | Experimental | Patients with spontaneous or drug-induced Brugada Syndrome 1 |
|
| Controls | Active Comparator | Patients with no condition associated with spontaneous or drug-induced Brugada Syndrome 1 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Patients affected by Brugada Syndrome 1 | Diagnostic Test | ECG analysis by Machine Learning algorithms and blood collection for the transcriptomic study of markers possibly associated with the disease |
| Measure | Description | Time Frame |
|---|---|---|
| Machine Learning recognition of Brugada Syndrome 1 | Identification of Brugada type 1 Syndrome coved ST component in a cohort of 44 patients (prospective study) and validated in a cohort of 100 patients (validation study) according to the diagnostic patterns related to Brugada Syndrome 1 on 12-leads ECG as already published on current international guidelines | Week 20 |
| Machine Learning recognition of Brugada Syndrome 1 | Identification of Brugada type 1 Syndrome QRS fragmentation component in a cohort of 44 patients (prospective study) and validated in a cohort of 100 patients (validation study) according to the diagnostic patterns related to Brugada Syndrome 1 on 12-leads ECG as already published on current international guidelines | Week 20 |
| Machine Learning recognition of Brugada Syndrome 1 | Identification and characterization of Brugada type 1 Syndrome T segment depression component in a cohort of 44 patients (prospective study) and validated in a cohort of 100 patients (validation study) according to the diagnostic patterns related to Brugada Syndrome 1 on 12-leads ECG as already published on current international guidelines | Week 20 |
| Machine Learning recognition of Brugada Syndrome 1 | Identification of Brugada type 1 Syndrome broad P wave with PQ prolongation component in a cohort of 44 patients (prospective study) and validated in a cohort of 100 patients (validation study) according to the diagnostic patterns related to Brugada Syndrome 1 on 12-leads ECG as already published on current international guidelines | Week 20 |
| Measure | Description | Time Frame |
|---|---|---|
| Biomarkers associated with Brugada Syndrome 1 | Identification of biomarkers associated with Brugada Syndrome 1 by the means of blood transcriptomic profile and exosomes analysis of patients. Transcriptomic and exosome could provide new insight into the pathophysiology of signalling in this pathology, as well as for application in Brugada Syndrome 1 diagnosis and therapeutics. Transcriptomic will provide a global picture of phenotypical changes associated with the disease, highlighting the potential genes involved in the development of Brugada Syndrome 1 The analysis of exosome coding and noncoding RNAs, participating in a variety of basic cellular functions, could also evidence potentially important pathophysiologic effects both in cardiac cells as well as on the release of electrical stimuli. The study will be performed in a cohort of 44 patients (prospective study) and results will be validated in a cohort of 100 patients (validation study) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Giorgio Iervasi, Dr. | Contact | +390503153302 | segreteria.direzione@ifc.cnr.it |
| Name | Affiliation | Role |
|---|---|---|
| Federico Vozzi, Ph.D. | Istituto di Fisiologia Clinica | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Azienda USL Toscana Sud Est - U.O.C Cardiologia | Arezzo | Tuscany | 52100 | Italy |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 1309182 | Background | Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992 Nov 15;20(6):1391-6. doi: 10.1016/0735-1097(92)90253-j. | |
| 27977610 | Background | Quan XQ, Li S, Liu R, Zheng K, Wu XF, Tang Q. A meta-analytic review of prevalence for Brugada ECG patterns and the risk for death. Medicine (Baltimore). 2016 Dec;95(50):e5643. doi: 10.1097/MD.0000000000005643. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D053840 | Brugada Syndrome |
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D000075224 | Cardiac Conduction System Disease |
Not provided
Not provided
| OTHER |
| Azienda Ospedaliero, Universitaria Pisana | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
| week 48 |
| Stratification risk | Development of stratification risk system for Brugada type 1 Syndrome by the integration of ECG Machine Learning algorithms and biomarkers. In particular, the module will combine the peculiar ECG patterns associated with BrS (coved ST, QRS fragmentation, T segment depression, broad P wave with PQ prolongation)(outcome 1-4) and omic (genes) and exosome markers (coding and noncoding RNAs)(outcome 5) with the aim to improve patient risk stratification. Specifically, gene expression modulation (expressed as % respect to control population) of Na+ (e.g., Nav1.5, Nav1.3, Nav2.1), Ca2+ (e.g. Cav3.1, HCN3) and K+ channels (e.g.,TWIK1, Kv4.3) will be evaluated. The study will be performed in a cohort of 44 patients (prospective study) and results will be validated in a cohort of 100 patients (validation study). | week 64 |
| Azienda Ospedaliera Universitaria Careggi - SOD Aritmologia | Florence | Tuscany | 50134 | Italy |
|
| Azienda Ospedaliero Universitaria Pisana - Cardiologia 2 | Pisa | Tuscany | 56100 | Italy |
|
| Fondazione Toscana Gabriele Monasterio | Pisa | Tuscany | 56124 | Italy |
|
| Istituto di Fisiologia Clinica IFC-CNR | Pisa | Tuscany | 56124 | Italy |
|
| Azienda Usl Toscana Nord Ovest - U.O.C. Cardiologia | Viareggio | Tuscany | 55049 | Italy |
|
| 29844648 | Background | Vutthikraivit W, Rattanawong P, Putthapiban P, Sukhumthammarat W, Vathesatogkit P, Ngarmukos T, Thakkinstian A. Worldwide Prevalence of Brugada Syndrome: A Systematic Review and Meta-Analysis. Acta Cardiol Sin. 2018 May;34(3):267-277. doi: 10.6515/ACS.201805_34(3).20180302B. |
| 15898165 | Background | Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. Brugada syndrome: report of the second consensus conference. Heart Rhythm. 2005 Apr;2(4):429-40. doi: 10.1016/j.hrthm.2005.01.005. |
| 12448445 | Background | Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RN, Kass RS, Nademanee K, Priori SG, Towbin JA; Study Group on the Molecular Basis of Arrhythmias of the European Society of Cardiology. Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J. 2002 Nov;23(21):1648-54. doi: 10.1053/euhj.2002.3382. No abstract available. |
| 25905440 | Background | Sarquella-Brugada G, Campuzano O, Arbelo E, Brugada J, Brugada R. Brugada syndrome: clinical and genetic findings. Genet Med. 2016 Jan;18(1):3-12. doi: 10.1038/gim.2015.35. Epub 2015 Apr 23. |
| 34645390 | Derived | Morales MA, Piacenti M, Nesti M, Solarino G, Pieragnoli P, Zucchelli G, Del Ry S, Cabiati M, Vozzi F. The BrAID study protocol: integration of machine learning and transcriptomics for brugada syndrome recognition. BMC Cardiovasc Disord. 2021 Oct 13;21(1):494. doi: 10.1186/s12872-021-02280-3. |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |